PLOD1 and cancer: When PBMCs were used as effector cells, Fc-LH-2HH11 also inhibited cancer cell growth effectively, but further improvements were not observed when additional high-affinity VL mutants, Fc-LH-2HH11-2L1 and Fc-LH-2HH11-2L6, were integrated (Fig. 3C).